-
1
-
-
14744268262
-
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
-
Antony PA, Restifo NP (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28(2): 120-128
-
(2005)
J Immunother
, vol.28
, Issue.2
, pp. 120-128
-
-
Antony, P.A.1
Restifo, N.P.2
-
2
-
-
0037428774
-
Metastatic renal carcinoma comprehensive prognostic system
-
doi:10.1038/sj.bjc.6600768
-
Atzpodien J, Royston P, Wandert T, Reitz M, DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Group (2003) Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88: 348-353, doi:10.1038/sj.bjc. 6600768
-
(2003)
Br J Cancer
, vol.88
, pp. 348-353
-
-
Atzpodien, J.1
Royston, P.2
Wandert, T.3
Reitz, M.4
-
3
-
-
11144354471
-
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
-
doi:10.1038/sj.bjc.6601617
-
Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J (2004) A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br J Cancer 90(5): 985-990, doi:10.1038/sj.bjc.6601617
-
(2004)
Br J Cancer
, vol.90
, Issue.5
, pp. 985-990
-
-
Bleumer, I.1
Knuth, A.2
Oosterwijk, E.3
Hofmann, R.4
Varga, Z.5
Lamers, C.6
Kruit, W.7
Melchior, S.8
Mala, C.9
Ullrich, S.10
De Mulder, P.11
Mulders, P.F.12
Beck, J.13
-
4
-
-
27144436068
-
-
UK Office of National Statistics
-
Cancer Registration Statistics (2001) Vol. 32. UK Office of National Statistics
-
(2001)
Cancer Registration Statistics
, vol.32
-
-
-
5
-
-
0029092020
-
Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane
-
Carsberg CJ, Myers KA, Evans GS, Allen TD, Stern PL (1995) Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci 108: 2905-2916
-
(1995)
J Cell Sci
, vol.108
, pp. 2905-2916
-
-
Carsberg, C.J.1
Myers, K.A.2
Evans, G.S.3
Allen, T.D.4
Stern, P.L.5
-
6
-
-
0029903794
-
Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells
-
Carsberg CJ, Myers KA, Stern PL (1996) Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer 68(1): 84-92
-
(1996)
Int J Cancer
, vol.68
, Issue.1
, pp. 84-92
-
-
Carsberg, C.J.1
Myers, K.A.2
Stern, P.L.3
-
7
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytoxicity against tumour targets
-
Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytoxicity against tumour targets. Nat Med 6: 443-446
-
(2000)
Nat Med
, vol.6
, pp. 443-446
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
8
-
-
0032850677
-
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
-
Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17: 2639-2648
-
(1999)
J Clin Oncol
, vol.17
, pp. 2639-2648
-
-
Cobleigh, M.A.1
Vogel, C.L.2
Tripathy, D.3
Robert, N.J.4
Scholl, S.5
Fehrenbacher, L.6
Wolter, J.M.7
Paton, V.8
Shak, S.9
Lieberman, G.10
Slamon, D.J.11
-
9
-
-
3042625811
-
A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced renal cell carcinoma (RCC)
-
Connolly NB, Shaw DM, Patel PM, Garner CM, Beirne D, Kilany S, Gunnar H, Forsberg G, Stern P, Hawkins RE (2003) A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced renal cell carcinoma (RCC). Proc Am Soc Clin Oncol 22: 177
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 177
-
-
Connolly, N.B.1
Shaw, D.M.2
Patel, P.M.3
Garner, C.M.4
Beirne, D.5
Kilany, S.6
Gunnar, H.7
Forsberg, G.8
Stern, P.9
Hawkins, R.E.10
-
10
-
-
13244288836
-
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up
-
DOI: 10.1200/JCO.2004.04.020
-
Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ (2005) Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 23(1): 248, DOI: 10.1200/JCO.2004.04.020
-
(2005)
J Clin Oncol
, vol.23
, Issue.1
, pp. 248
-
-
Czuczman, M.S.1
Weaver, R.2
Alkuzweny, B.3
Berlfein, J.4
Grillo-Lopez, A.J.5
-
11
-
-
0034177140
-
Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL
-
Darcy PK, Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ (2000) Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL. J Immunol 164: 3705-3712
-
(2000)
J Immunol
, vol.164
, pp. 3705-3712
-
-
Darcy, P.K.1
Haynes, N.M.2
Snook, M.B.3
Trapani, J.A.4
Cerruti, L.5
Jane, S.M.6
Smyth, M.J.7
-
12
-
-
14044271554
-
Tumour-infiltrating lymphocytes and interleukin-2: Dose and schedules of administration in the treatment of metastatic cancer
-
Dillman R, Schiltz P, DePriest C, Barth N, Beutel L, de Leon C, O'Connor A, Nayak S (2004) Tumour-infiltrating lymphocytes and interleukin-2: dose and schedules of administration in the treatment of metastatic cancer. Cancer Biother Radiopharm 19(6): 730-737
-
(2004)
Cancer Biother Radiopharm
, vol.19
, Issue.6
, pp. 730-737
-
-
Dillman, R.1
Schiltz, P.2
DePriest, C.3
Barth, N.4
Beutel, L.5
De Leon, C.6
O'Connor, A.7
Nayak, S.8
-
13
-
-
0038514926
-
To bead or not to bead
-
Dudley M (2003) To bead or not to bead. J Immunother 6(3): 187-189
-
(2003)
J Immunother
, vol.6
, Issue.3
, pp. 187-189
-
-
Dudley, M.1
-
14
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumour lymphocytes
-
Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumour lymphocytes. Science 298(5594): 850-854
-
(2002)
Science
, vol.298
, Issue.5594
, pp. 850-854
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Robbins, P.F.3
Yang, J.C.4
Hwu, P.5
Schwartzentruber, D.J.6
Topalian, S.L.7
Sherry, R.8
Restifo, N.P.9
Hubicki, A.M.10
Robinson, M.R.11
Raffeld, M.12
Duray, P.13
Seipp, C.A.14
Rogers-Freezer, L.15
Morton, K.E.16
Mavroukakis, S.A.17
White, D.E.18
Rosenberg, S.A.19
-
15
-
-
0032784492
-
Multicenter, randomized, phase III trial of CD8(+) tumour-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma
-
Figlin RA, Thompson JA, Bukowski RM, Vogelzang NJ, Novick AC, Lange P, Steinberg GD, Belldegrun AS (1999) Multicenter, randomized, phase III trial of CD8(+) tumour-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol 17(8): 2521-2529
-
(1999)
J Clin Oncol
, vol.17
, Issue.8
, pp. 2521-2529
-
-
Figlin, R.A.1
Thompson, J.A.2
Bukowski, R.M.3
Vogelzang, N.J.4
Novick, A.C.5
Lange, P.6
Steinberg, G.D.7
Belldegrun, A.S.8
-
16
-
-
0028097848
-
Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
-
Finer MH, Dull TJ, Qin L, Farson D, Roberts MR (1994) kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83: 43-50
-
(1994)
Blood
, vol.83
, pp. 43-50
-
-
Finer, M.H.1
Dull, T.J.2
Qin, L.3
Farson, D.4
Roberts, M.R.5
-
17
-
-
0035294391
-
A decade in the life of tumour immunology
-
Finn OJ, Lotze MT (2001) A decade in the life of tumour immunology. Clin Cancer Res 7(Suppl 3): 759s-760s
-
(2001)
Clin Cancer Res
, vol.7
, Issue.3 SUPPL.
-
-
Finn, O.J.1
Lotze, M.T.2
-
18
-
-
0031080901
-
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
-
Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18: 89-95
-
(1997)
Immunol Today
, vol.18
, pp. 89-95
-
-
Garrido, F.1
Ruiz-Cabello, F.2
Cabrera, T.3
Perez-Villar, J.J.4
Lopez-Botet, M.5
Duggan-Keen, M.6
Stern, P.L.7
-
19
-
-
0036193484
-
Primary polyclonal human t lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumour antigens by CD3z-based chimeric immune receptors
-
Gilham DE, O'Neill A, Hughes C, Guest RD, Kirillova N, Lehane M, Hawkins RE (2002) Primary polyclonal human t lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumour antigens by CD3z-based chimeric immune receptors. J Immunother 25(2): 139-151
-
(2002)
J Immunother
, vol.25
, Issue.2
, pp. 139-151
-
-
Gilham, D.E.1
O'Neill, A.2
Hughes, C.3
Guest, R.D.4
Kirillova, N.5
Lehane, M.6
Hawkins, R.E.7
-
20
-
-
0029094721
-
Adoptive immunotherapy with tumour-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: A pilot study
-
Goedegebuure PS, Douville LM, Li H, Richmond GC, Schoof DD, Scavone M, Eberlein TJ (1995) Adoptive immunotherapy with tumour-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. J Clin Oncol 13(8): 1939-1949
-
(1995)
J Clin Oncol
, vol.13
, Issue.8
, pp. 1939-1949
-
-
Goedegebuure, P.S.1
Douville, L.M.2
Li, H.3
Richmond, G.C.4
Schoof, D.D.5
Scavone, M.6
Eberlein, T.J.7
-
21
-
-
20944439742
-
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: Evaluation of four different scFvs and antigens
-
Guest RD, Hawkins RE, Kirillova N, Cheadle EJ, Arnold J, O'Neill A, Irlam J, Chester KA, Kemshead J, Shaw D, Embleton J, Stern PL, Gilham DE (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens. J Immunother 28(3): 203-211
-
(2005)
J Immunother
, vol.28
, Issue.3
, pp. 203-211
-
-
Guest, R.D.1
Hawkins, R.E.2
Kirillova, N.3
Cheadle, E.J.4
Arnold, J.5
O'Neill, A.6
Irlam, J.7
Chester, K.A.8
Kemshead, J.9
Shaw, D.10
Embleton, J.11
Stern, P.L.12
Gilham, D.E.13
-
22
-
-
0023818391
-
A 72 kDa trophoblast glycoprotein defined by a monoclonal antibody
-
Hole N, Stern PL (1988) A 72 kDa trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer 57: 237-246
-
(1988)
Br J Cancer
, vol.57
, pp. 237-246
-
-
Hole, N.1
Stern, P.L.2
-
23
-
-
0033302303
-
Transport of molecules, particles and cells in solid tumours
-
doi:10.1146/annurev.bioeng.1.1.241
-
Jain RK (1999) Transport of molecules, particles and cells in solid tumours. Ann Rev Bio Eng 1: 241-263, doi:10.1146/annurev.bioeng.1.1.241
-
(1999)
Ann Rev Bio Eng
, vol.1
, pp. 241-263
-
-
Jain, R.K.1
-
24
-
-
10744230275
-
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: Phase III, randomised controlled trial
-
Jocham D, Richter A, Hoffmann L, Iwig K, Fahlenkamp D, Zakrzewski G, Schmitt E, Dannenberg T, Lehmacher W, von Wietersheim J, Doehn C (2004) Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 363: 594-599
-
(2004)
Lancet
, vol.363
, pp. 594-599
-
-
Jocham, D.1
Richter, A.2
Hoffmann, L.3
Iwig, K.4
Fahlenkamp, D.5
Zakrzewski, G.6
Schmitt, E.7
Dannenberg, T.8
Lehmacher, W.9
Von Wietersheim, J.10
Doehn, C.11
-
25
-
-
4143149381
-
Identification of multiple antigens recognized by tumour-infiltrating lymphocytes from a single patient: Tumour escape by antigen loss and loss of MHC expression
-
Khong HT, Wang QT, Rosenber SA (2004) Identification of multiple antigens recognized by tumour-infiltrating lymphocytes from a single patient: tumour escape by antigen loss and loss of MHC expression. J Immunother 27(3): 184-190
-
(2004)
J Immunother
, vol.27
, Issue.3
, pp. 184-190
-
-
Khong, H.T.1
Wang, Q.T.2
Rosenber, S.A.3
-
26
-
-
0036019378
-
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
-
Lamers CH, Willemsen RA, Luider BA, Debets R, Bolhuis RL (2002) Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. Cancer Gene Ther 9(7): 613-623
-
(2002)
Cancer Gene Ther
, vol.9
, Issue.7
, pp. 613-623
-
-
Lamers, C.H.1
Willemsen, R.A.2
Luider, B.A.3
Debets, R.4
Bolhuis, R.L.5
-
27
-
-
0033965065
-
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms
-
Le X, McWatters A, Wiener J, Wu J, Mills GB, Bast RC (2000) Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms. Clin Cancer Res 6: 260-270
-
(2000)
Clin Cancer Res
, vol.6
, pp. 260-270
-
-
Le, X.1
McWatters, A.2
Wiener, J.3
Wu, J.4
Mills, G.B.5
Bast, R.C.6
-
28
-
-
0035974910
-
VHL gene alterations in renal cell carcinoma patients: Novel hotspots or founder mutations and linkage disequilibrium
-
Ma X, Yang K, Lindblad P, Egevad L, Hemminki K (2001) VHL gene alterations in renal cell carcinoma patients: novel hotspots or founder mutations and linkage disequilibrium. Oncogene 20: 5393-5400
-
(2001)
Oncogene
, vol.20
, pp. 5393-5400
-
-
Ma, X.1
Yang, K.2
Lindblad, P.3
Egevad, L.4
Hemminki, K.5
-
29
-
-
1842562212
-
Tolerance and cancer: Mechanisms of tumour evasion and strategies for breaking tolerance
-
DOI: 10.1200/JCO.2004.10.041
-
Mapara YM, Sykes M (2004) Tolerance and cancer: mechanisms of tumour evasion and strategies for breaking tolerance. J Clin Oncol 22(6): 1136-1151, DOI: 10.1200/JCO.2004.10.041
-
(2004)
J Clin Oncol
, vol.22
, Issue.6
, pp. 1136-1151
-
-
Mapara, Y.M.1
Sykes, M.2
-
30
-
-
0033514050
-
Interferon-alpha and survival in metastatic renal carcinoma: Early results of a randomised controlled trial
-
MRC Renal Cancer Collaborators (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 353: 14-17
-
(1999)
Lancet
, vol.353
, pp. 14-17
-
-
-
31
-
-
1842848097
-
Attenuated recombinant vaccinia virus expressing oncofoetal antigen (tumour-associated antigen) 5T4 induces active therapy of established tumours
-
Mulryan K, Ryan MG, Myers KA, Shaw D, Wang W, Kingsman SM, Stern PL, Carroll MW (2002) Attenuated recombinant vaccinia virus expressing oncofoetal antigen (tumour-associated antigen) 5T4 induces active therapy of established tumours. Mol Cancer Ther 1: 1129-1137
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 1129-1137
-
-
Mulryan, K.1
Ryan, M.G.2
Myers, K.A.3
Shaw, D.4
Wang, W.5
Kingsman, S.M.6
Stern, P.L.7
Carroll, M.W.8
-
32
-
-
0028340558
-
Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats
-
Myers KA, Rahi-Saund V, Davison MD, Young JA, Cheater AJ, Stern PL (1994) Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem 269(12): 9319-9324
-
(1994)
J Biol Chem
, vol.269
, Issue.12
, pp. 9319-9324
-
-
Myers, K.A.1
Rahi-Saund, V.2
Davison, M.D.3
Young, J.A.4
Cheater, A.J.5
Stern, P.L.6
-
33
-
-
1642321982
-
IL-2, regulatory T-cells and tolerance
-
Nelson BH (2004) IL-2, regulatory T-cells and tolerance. J Immunol 172(7): 3983-3988
-
(2004)
J Immunol
, vol.172
, Issue.7
, pp. 3983-3988
-
-
Nelson, B.H.1
-
34
-
-
0022502868
-
Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney
-
Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EK, Jonas U, Zwartendijk J, Warnaar SO (1986) Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 38(4): 489-494
-
(1986)
Int J Cancer
, vol.38
, Issue.4
, pp. 489-494
-
-
Oosterwijk, E.1
Ruiter, D.J.2
Hoedemaeker, P.J.3
Pauwels, E.K.4
Jonas, U.5
Zwartendijk, J.6
Warnaar, S.O.7
-
35
-
-
0028878938
-
Problems of delivery of monoclonal antibodies: Pharmaceutical and pharmacokinetic solutions
-
Reilly RM, Sandhu J, Alvarez-Diez TM, Gallinger S, Kirsh J, Stern H (1995) Problems of delivery of monoclonal antibodies: pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet 28: 126-142
-
(1995)
Clin Pharmacokinet
, vol.28
, pp. 126-142
-
-
Reilly, R.M.1
Sandhu, J.2
Alvarez-Diez, T.M.3
Gallinger, S.4
Kirsh, J.5
Stern, H.6
-
36
-
-
0038315362
-
Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastases
-
Sheen AJ, Irlam J, Kirillova N, Guest RD, Sherlock DJ, Hawkins RE, Gilham DE (2003) Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastases. Dis Colon Rectum 46(6): 793-804
-
(2003)
Dis Colon Rectum
, vol.46
, Issue.6
, pp. 793-804
-
-
Sheen, A.J.1
Irlam, J.2
Kirillova, N.3
Guest, R.D.4
Sherlock, D.J.5
Hawkins, R.E.6
Gilham, D.E.7
-
37
-
-
0025109257
-
Immunological distribution of 5T4 antigen in normal and malignant tissues
-
Southall PJ, Boxer GM, Bagshaw KD, Hole N, Bromley M, Stern PL (1990) Immunological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 61: 89-95
-
(1990)
Br J Cancer
, vol.61
, pp. 89-95
-
-
Southall, P.J.1
Boxer, G.M.2
Bagshaw, K.D.3
Hole, N.4
Bromley, M.5
Stern, P.L.6
-
38
-
-
0028324131
-
Prognostic significance of 5T4 oncofoetal antigen expression in colorectal carcinoma
-
Starzynska T, Marsh PJ, Schofield PF, Roberts SA, Myers KA, Stern PL (1994) Prognostic significance of 5T4 oncofoetal antigen expression in colorectal carcinoma. Br J Cancer 69: 899-902
-
(1994)
Br J Cancer
, vol.69
, pp. 899-902
-
-
Starzynska, T.1
Marsh, P.J.2
Schofield, P.F.3
Roberts, S.A.4
Myers, K.A.5
Stern, P.L.6
-
39
-
-
14244265418
-
Engineering T-cells with antibody-based chimeric receptors for effective cancer therapy
-
Thistlethwaite F, Mansoor W, Gilham DE, Hawkins RE (2005) Engineering T-cells with antibody-based chimeric receptors for effective cancer therapy. Curr Opin Mol Ther 7(1): 48-55
-
(2005)
Curr Opin Mol Ther
, vol.7
, Issue.1
, pp. 48-55
-
-
Thistlethwaite, F.1
Mansoor, W.2
Gilham, D.E.3
Hawkins, R.E.4
-
40
-
-
21344432170
-
Phase I study of escalating doses of TroVax in patients with advanced colorectal cancer
-
Valle JW, Connolly NB, Harrop R, McNeill H, Garner CM, Fenemore J, Saunders MP, Kingsman S, Carroll MW, Hawkins RE (2003) Phase I study of escalating doses of TroVax in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 22: 181
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 181
-
-
Valle, J.W.1
Connolly, N.B.2
Harrop, R.3
McNeill, H.4
Garner, C.M.5
Fenemore, J.6
Saunders, M.P.7
Kingsman, S.8
Carroll, M.W.9
Hawkins, R.E.10
-
41
-
-
0035394516
-
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas
-
Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jurgensen JS, Gruber G, Maxwell PH, Loning SA, Frei U, Maher ER, Grone HJ, Eckardt KU (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 61(13): 5215-5222
-
(2001)
Cancer Res
, vol.61
, Issue.13
, pp. 5215-5222
-
-
Wiesener, M.S.1
Munchenhagen, P.M.2
Berger, I.3
Morgan, N.V.4
Roigas, J.5
Schwiertz, A.6
Jurgensen, J.S.7
Gruber, G.8
Maxwell, P.H.9
Loning, S.A.10
Frei, U.11
Maher, E.R.12
Grone, H.J.13
Eckardt, K.U.14
-
42
-
-
0037097840
-
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin's lymphoma and mild thrombocytopenia: A phase II multicenter trial
-
Wiseman GA, Gordon LI, Multani PS, Witzig TE, Spies S, Bartlett NL, Schilder RJ, Murray JL, Saleh M, Allen RS, Grillo-Lopez AJ, White CA (2002) Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin's lymphoma and mild thrombocytopenia: a phase II multicenter trial. Blood 99: 4336-4342
-
(2002)
Blood
, vol.99
, pp. 4336-4342
-
-
Wiseman, G.A.1
Gordon, L.I.2
Multani, P.S.3
Witzig, T.E.4
Spies, S.5
Bartlett, N.L.6
Schilder, R.J.7
Murray, J.L.8
Saleh, M.9
Allen, R.S.10
Grillo-Lopez, A.J.11
White, C.A.12
-
43
-
-
0042914703
-
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer
-
Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA (2003) Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 21(16): 3127-3132
-
(2003)
J Clin Oncol
, vol.21
, Issue.16
, pp. 3127-3132
-
-
Yang, J.C.1
Sherry, R.M.2
Steinberg, S.M.3
Topalian, S.L.4
Schwartzentruber, D.J.5
Hwu, P.6
Seipp, C.A.7
Rogers-Freezer, L.8
Morton, K.E.9
White, D.E.10
Liewehr, D.J.11
Merino, M.J.12
Rosenberg, S.A.13
|